Shanjin Capital

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

Echemi is a professional B2B digital commerce platform for chemicals that provides buyers with global trade data and a chemical products market report and is one of the most popular platforms for global chemical buyers. From raw material selection, procurement, transportation, and customs clearance to product application and marketing channels, ECHEMI offers comprehensive and efficient solutions. Additionally, the business offers weekly price and market analyses for more than 500 raw materials across the four industries of coatings, fine chemicals, food & nutrition, and pharmaceuticals.

Nenghua Microelectronics is a gallium nitride power device and chip developer. The company's products include epitaxial wafers, diodes, power devices, chips and modules, etc.; in addition, the company also involves laser stripping, MOCVD bakeware cleaning, HAST coating and other businesses And to provide compound semiconductor users with foundry services in the field of research and development.

Bailian.ai is an artificial intelligence company that specializes in providing intelligent customer service. It aims to apply AI technology to deepen unstructured business information on the Internet into structured sales leads to help improve customers. Efficiency, reducing the cost of getting customers. Bailian Smart is committed to the development of automated knowledge generation technology based on deep learning, collecting, cleaning, extracting, screening and rewriting business information, refining it into precise and trustworthy knowledge and enhancing business awareness.

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.